Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$1.7B |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$505M |
| 3 |
Johnson & Johnson
JNJ
|
+$441M |
| 4 |
Mastercard
MA
|
+$406M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$394M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.61B |
| 2 |
NVIDIA
NVDA
|
+$1.42B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$907M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$716M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.3% |
| 2 | Financials | 8.57% |
| 3 | Healthcare | 7.58% |
| 4 | Consumer Discretionary | 7.43% |
| 5 | Industrials | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UROY
5451
Uranium Royalty Corp
UROY
$1.3B
| $159K | ﹤0.01% |
64,960
+1,012
| +2% | +$2.28K |
|
|
MURA
5452
DELISTED
Mural Oncology
MURA
| $157K | ﹤0.01% |
50,186
-129,421
| -72% | -$421K |
|
5453
Purple Innovation
PRPL
$42.9M
| $156K | ﹤0.01% |
6,324
-324
| -5% | -$9.35K |
|
5454
Neuropace
NPCE
$474M
| $156K | ﹤0.01% |
22,426
-1,522
| -6% | -$11.1K |
|
|
AILE
5455
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $155K | ﹤0.01% |
+93,039
| New | +$475K |
|
|
NNE
5456
Nano Nuclear Energy
NNE
$980M
| $155K | ﹤0.01% |
+10,775
| New | +$151K |
|
5457
Ovid Therapeutics
OVID
$459M
| $154K | ﹤0.01% |
130,279
+3,453
| +3% | +$3.61K |
|
5458
LivePerson
LPSN
$27.7M
| $153K | ﹤0.01% |
7,966
-55,521
| -87% | -$941K |
|
5459
DLH Holdings
DLHC
$71.3M
| $153K | ﹤0.01% |
16,295
-6,274
| -28% | -$66.1K |
|
5460
Fractyl Health
GUTS
$111M
| $151K | ﹤0.01% |
59,570
+41,149
| +223% | +$134K |
|
5461
Eve Holding
EVEX
$958M
| $149K | ﹤0.01% |
+45,970
| New | +$139K |
|
|
FAZ
5462
Direxion Daily Financial Bear 3x ETF
FAZ
$85.2M
| $149K | ﹤0.01% |
18,811
-1,348
| -7% | -$10.7K |
|
5463
Precision BioSciences
DTIL
$186M
| $146K | ﹤0.01% |
16,306
+532
| +3% | +$5.12K |
|
|
AKYA
5464
DELISTED
Akoya BioSciences
AKYA
| $144K | ﹤0.01% |
52,889
+39,563
| +297% | +$96.6K |
|
5465
PetMed Express
PETS
$42.3M
| $144K | ﹤0.01% |
39,063
-300,913
| -89% | -$1.07M |
|
|
NEXN
5466
Nexxen International
NEXN
$576M
| $142K | ﹤0.01% |
17,605
| – | – |
|
|
UBFO
5467
DELISTED
United Security Bancshares
UBFO
| $141K | ﹤0.01% |
16,185
+2,572
| +19% | +$20.4K |
|
|
BZUN
5468
Baozun
BZUN
$177M
| $141K | ﹤0.01% |
+39,314
| New | +$97.2K |
|
|
LYRA
5469
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $141K | ﹤0.01% |
10,947
+10,459
| +2,143% | +$154K |
|
5470
Bioceres Crop Solutions
BIOX
$24.3M
| $141K | ﹤0.01% |
17,872
+4,211
| +31% | +$42.5K |
|
5471
Northern Technologies International Corp
NTIC
$79.9M
| $139K | ﹤0.01% |
11,287
+846
| +8% | +$11.2K |
|
|
WPRT
5472
Westport Fuel Systems
WPRT
$33.8M
| $136K | ﹤0.01% |
29,700
| – | – |
|
5473
Cibus
CBUS
$147M
| $136K | ﹤0.01% |
41,691
-44,985
| -52% | -$326K |
|
5474
CALL
Agilon Health
AGL
$1.53B
| $136K | ﹤0.01% |
1,380
| – | – |
|
5475
374Water
SCWO
$40.2M
| $135K | ﹤0.01% |
9,919
+8,085
| +441% | +$98.2K |
|
Similar funds
Goldman Sachs's Q3 2024 Portfolio in Review
As of Q3 2024, Goldman Sachs held 6,216 positions worth $621B, up 5% from $591B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q3 2024 filing shows 596 new, 2,752 increased, 1,995 reduced and 427 closed positions. Its largest new stake was Smurfit Westrock: 3,644,566 shares worth $180M. The largest sale was Tesla, an estimated $1.61B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q3 2024 buy was Smurfit Westrock: 3,644,566 shares worth $180M.
- Goldman Sachs added most to TC Energy in Q3 2024, an estimated $1.7B increase.
- Goldman Sachs's biggest Q3 2024 reduction was Tesla, cutting an estimated $1.61B.
- Goldman Sachs fully exited WestRock Company in Q3 2024, selling an estimated $204M.
- Goldman Sachs's ten largest holdings make up 19% of its $621B portfolio in Q3 2024.
- Goldman Sachs opened 596 new positions and closed 427 in Q3 2024.
- Goldman Sachs's portfolio value rose 5% quarter-over-quarter to $621B.
Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.